FDA approves Endologix's PowerFit extensions to improve stent placement
This article was originally published in Clinica
Executive Summary
Endologix's PowerFit aortic extensions have been approved by the US FDA, via a premarket approval (PMA) supplement. The extensions are designed to allow the precise placement of devices such as stents during the repair of abdominal aortic aneurysms. The PowerFit devices, which are visible under fluoroscopy, will be available in a range of sizes, and can be used with Endologix's existing products, including Powerlink bifurcated stents and the IntuiTrak endovascular system. The Irvine, California firm plans a limited launch of the products during the third quarter, followed by full US release in the fourth quarter.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.